By physician referral or invitation only

A Phase III study of AZD0780 on major adverse CV events in patients with a history of ASCVD events or at high risk for a first event

This study is designed to assess the effect of AZD0780 compared with placebo in reducing the risk of major cardiovascular events (MACE)-PLUS in patients with established ASCVD or those at high risk for a first ASCVD event.

Age & Gender

18 years ~ 99 years
Male, Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Matthew Cavender
Medicine - Cardiology

Study Type

Clinical or Medical
Interventional

Study Topics

Heart and Circulation

IRB Number

25-2252

ClinicalTrials.gov

NCT07000357

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.